The Hybridoma Clone 2B4. 5C9, produces monoclonal antibodies that are specific to an abundant malaria protein called aldolase, which recognizes all species of Plasmodium._x000D_ The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.
| Institute |
|---|
| Johns Hopkins University |
| Cat. #: | 156422 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Immunology;Microbiology |
| Application: | IHC |
| Target: | aldolase |
| Class: | Monoclonal |
| Product description: | The Hybridoma Clone 2B4. 5C9, produces monoclonal antibodies that are specific to an abundant malaria protein called aldolase, which recognizes all species of Plasmodium. The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite. |
|---|---|
| Conjugation: | Unconjugated |
| Target background: | The Hybridoma Clone 2B4. 5C9, produces monoclonal antibodies that are specific to an abundant malaria protein called aldolase, which recognizes all species of Plasmodium. The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.